All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

James Edgerton, MD, FACS, FACC, FHRS
Disclosure(s): AtriCure: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

J.W. Awori Hayanga, MD, MPH, FACS

Presentations

1. Frailty Assessment: Cardiac Surgery Perspective
   Rakesh C. Arora, MD, PhD, FRCSC
   Disclosure(s): Edwards LifeSciences: Speaker/Honoraria (Terminated, January 1, 2022); HLS Therapeutics Inc: Speaker/Honoraria (Terminated, September 21, 2022); Renibus Therapeutics Inc.: Advisory Board (Ongoing)
    
2. Frailty Assessment: Thoracic Surgery Perspective
   Maria Lucia L. Madariaga, MD
    
3. Lessons Learned: How the ACC Has Implemented Frailty Assessment
   Ajar Kochar, MD, MHS
   Disclosure(s): Abiomed Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Faraday Pharmaceuticals: Consultant (Ongoing); Rampart Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Shockwave Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
    
4. Collection of Frailty Data in the STS National Databases: What's Coming
   Moritz C. Wyler von Ballmoos, MD, PhD, MPH
   Disclosure(s): Medtronic: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing)
    
5. Frailty Assessment 2.0: New Gadgets
   Jonathan Afilalo, MD MSc